We are live on ! Find out more
NXGN

NextGen Healthcare, Inc. Common Stock

Delisted

NXGN was delisted on the 8th of November, 2023.

180 hedge funds and large institutions have $667M invested in NextGen Healthcare, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 68 increasing their positions, 51 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,607% more call options, than puts

Call options by funds: $3.23M | Put options by funds: $189K

33% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 51

18% more capital invested

Capital invested by funds: $565M → $667M (+$102M)

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

2% less funds holding

Funds holding: 184180 (-4)

Holders
180
Holders Change
-4
Holders Change %
-2.17%
% of All Funds
4.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
68
Reduced
51
Closed
26
Calls
$3.23M
Puts
$189K
Net Calls
+$3.04M
Net Calls Change
-$577K
Name Holding Trade Value Shares
Change
Change in
Stake
NFA
26
Nationwide Fund Advisors
Ohio
$4.85M -$40.1K -2,722 -0.8%
AllianceBernstein
27
AllianceBernstein
Tennessee
$4.76M +$3.36M +228,090 +270%
Two Sigma Investments
28
Two Sigma Investments
New York
$4.55M -$160K -10,855 -4%
FAM
29
Fred Alger Management
New York
$4.45M -$4.33M -293,924 -50%
Goldman Sachs
30
Goldman Sachs
New York
$4.19M +$1.8M +122,290 +80%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$4.03M +$241K +16,364 +7%
Ameriprise
32
Ameriprise
Minnesota
$3.94M +$172K +11,712 +5%
Morgan Stanley
33
Morgan Stanley
New York
$3.92M -$82.7K -5,616 -2%
FP
34
Foundry Partners
Minnesota
$3.71M +$3.58M +243,199 New
Boston Partners
35
Boston Partners
Massachusetts
$3.62M
TCIM
36
TIAA CREF Investment Management
New York
$3.02M +$112K +7,577 +4%
MC
37
Menta Capital
California
$3.01M -$388K -26,353 -12%
AIM
38
Alambic Investment Management
California
$2.99M +$713K +48,400 +33%
Renaissance Technologies
39
Renaissance Technologies
New York
$2.64M -$1.26M -85,719 -33%
CIP
40
Chartwell Investment Partners
Pennsylvania
$2.56M +$2.47M +167,701 New
AG
41
Algert Global
California
$2.43M +$454K +30,797 +24%
Axa
42
Axa
France
$2.29M
HighTower Advisors
43
HighTower Advisors
Illinois
$2.18M +$2.11M +143,099 New
Prudential Financial
44
Prudential Financial
New Jersey
$2.11M +$108K +7,350 +6%
JP Morgan Chase
45
JP Morgan Chase
New York
$1.93M +$1.85M +125,951 +20,380%
Jacobs Levy Equity Management
46
Jacobs Levy Equity Management
New Jersey
$1.9M +$264K +17,940 +17%
SFM
47
Systematic Financial Management
New Jersey
$1.88M -$31.6K -2,145 -2%
PPA
48
Parametric Portfolio Associates
Washington
$1.78M -$157K -10,659 -8%
Bank of America
49
Bank of America
North Carolina
$1.74M +$573K +38,915 +52%
Deutsche Bank
50
Deutsche Bank
Germany
$1.66M -$649K -44,078 -29%

NXGN Hedge Fund Activity: Q1 2017 in Review

180 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in NextGen Healthcare, Inc. Common Stock (NXGN) for Q1 2017, worth a combined $667M — up 18% from $565M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new NXGN positions and 26 closed out — a net gain of 3 holders — while 68 added to existing stakes and 51 trimmed.

The largest buyer was BlackRock, adding an estimated $84.6M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $9.82M sold.

  • 180 institutional investors held NextGen Healthcare, Inc. Common Stock (NXGN) as of Q1 2017, down from 184 in Q4 2016.
  • Funds reported $667M of NextGen Healthcare, Inc. Common Stock stock for Q1 2017, up 18% quarter-over-quarter.
  • 29 funds opened new NextGen Healthcare, Inc. Common Stock positions in Q1 2017 and 26 closed out, a net change of +3 holders.
  • The largest NextGen Healthcare, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $84.6M added.
  • The largest NextGen Healthcare, Inc. Common Stock seller in Q1 2017 was PFM Health Sciences, an estimated $9.82M sold.

Based on aggregated 13F filings for Q1 2017.